BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33522823)

  • 21. Crosstalk between Tumor-Associated Macrophages and MicroRNAs: A Key Role in Tumor Microenvironment.
    Zhou X; Chen B; Zhang Z; Huang Y; Li J; Wei Q; Cao D; Ai J
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
    Rong X; Huang B; Qiu S; Li X; He L; Peng Y
    Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
    Liu PF; Cao YW; Zhang SD; Zhao Y; Liu XG; Shi HQ; Hu KY; Zhu GQ; Ma B; Niu HT
    Oncotarget; 2015 Nov; 6(35):37695-705. PubMed ID: 26462177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment.
    Shiri S; Alizadeh AM; Baradaran B; Farhanghi B; Shanehbandi D; Khodayari S; Khodayari H; Tavassoli A
    Asian Pac J Cancer Prev; 2015; 16(9):3917-22. PubMed ID: 25987060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
    Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
    Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers.
    Shen L; Li J; Liu Q; Song W; Zhang X; Tiruthani K; Hu H; Das M; Goodwin TJ; Liu R; Huang L
    ACS Nano; 2018 Oct; 12(10):9830-9841. PubMed ID: 30253648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
    Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
    J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
    Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
    Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment.
    Wilson R; Espinosa-Diez C; Kanner N; Chatterjee N; Ruhl R; Hipfinger C; Advani SJ; Li J; Khan OF; Franovic A; Weis SM; Kumar S; Coussens LM; Anderson DG; Chen CC; Cheresh DA; Anand S
    Nat Commun; 2016 Nov; 7():13597. PubMed ID: 27886180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
    Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
    J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 32. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages.
    Smirnova T; Bonapace L; MacDonald G; Kondo S; Wyckoff J; Ebersbach H; Fayard B; Doelemeyer A; Coissieux MM; Heideman MR; Bentires-Alj M; Hynes NE
    Oncotarget; 2016 Dec; 7(50):82289-82304. PubMed ID: 27793045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity.
    Liu L; Chen Q; Ruan C; Chen X; Zhang Y; He X; Zhang Y; Lu Y; Guo Q; Sun T; Wang H; Jiang C
    Theranostics; 2018; 8(11):2974-2987. PubMed ID: 29896297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
    Li M; Zhang F; Su Y; Zhou J; Wang W
    Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.
    Lo YL; Chang CH; Wang CS; Yang MH; Lin AM; Hong CJ; Tseng WH
    Theranostics; 2020; 10(15):6695-6714. PubMed ID: 32550898
    [No Abstract]   [Full Text] [Related]  

  • 37. Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.
    Patel H; Nilendu P; Jahagirdar D; Pal JK; Sharma NK
    Cancer Biol Ther; 2018 Jan; 19(1):3-12. PubMed ID: 29219656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
    Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
    Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reshaping Prostate Tumor Microenvironment To Suppress Metastasis
    Lang J; Zhao X; Qi Y; Zhang Y; Han X; Ding Y; Guan J; Ji T; Zhao Y; Nie G
    ACS Nano; 2019 Nov; 13(11):12357-12371. PubMed ID: 31545587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of Stability and Efficacy of C16Y Therapeutic Peptide via Molecular Self-Assembly into Tumor-Responsive Nanoformulation.
    Ding Y; Ji T; Zhao Y; Zhang Y; Zhao X; Zhao R; Lang J; Zhao X; Shi J; Sukumar S; Nie G
    Mol Cancer Ther; 2015 Oct; 14(10):2390-400. PubMed ID: 26269603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.